Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pahtology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus collection and preservation system; and multi-omics platform services. It also provides DP-TOF nucleic acid mass spectrometry solutions, including mass spectroscopy system, automatic sample processing system, respiratory pathogens multiple detection kit, and nucleic acid sample pretreatment reagent kit; and forensic drug testing products comprises diangio, hair drug trace tester and detector, and saliva and urine drug testing product series. In addition, the company provides supply chain optimization, information management, cold chain logistics, intelligent warehousing, sample library management, scientific research services, etc., as well as solutions for laboratory quality. It is involved in the research, development of diagnostic products and vitro diagnostic reagents, as well as forensic identification, health management, and other fields. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.
Metrics to compare | 300244 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300244PeersSector | |
---|---|---|---|---|
P/E Ratio | −23.9x | 15.3x | −0.5x | |
PEG Ratio | 0.07 | −0.43 | 0.00 | |
Price/Book | 1.5x | 1.0x | 2.6x | |
Price / LTM Sales | 0.8x | 0.6x | 3.2x | |
Upside (Analyst Target) | −20.3% | 14.1% | 41.9% | |
Fair Value Upside | Unlock | 16.2% | 4.3% | Unlock |